Brief: Vascular Biogenics - Following Execution Of Term Sheet With Wellbeing Group On June 30, Parties Negotiated A Definitive Asset Purchase Agreement
Oct 2 (Reuters) - Vascular Biogenics Ltd VBLT.O :
* VASCULAR BIOGENICS- FOLLOWING EXECUTION OF TERM SHEET
WITH
WELLBEING GROUP ON JUNE 30, PARTIES NEGOTIATED A DEFINITIVE
ASSET PURCHASE AGREEMENT
* VASCULAR BIOGENICS- DEFINITIVE ASSET PURCHASE AGREEMENT
FOR
SALE OF VB-601 AND MOSPD2 RELATED ASSETS
* VASCULAR BIOGENICS LTD - VBL ENTERED INTO ASSET PURCHASE
AGREEMENT ON OCTOBER 1, 2023
Further company coverage: VBLT.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Notable Labs
See all newsUS STOCKS-Wall St ends sharply lower following Trump's anti-Powell tirade
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives